Workflow
圣诺生物(688117) - 2024 Q1 - 季度财报
SNSWSNSW(SH:688117)2024-04-22 10:52

Financial Performance - The company's operating revenue for Q1 2024 reached ¥104,057,251.91, representing a year-on-year increase of 27.65%[5] - The net profit attributable to shareholders was ¥16,472,225.12, reflecting a growth of 17.38% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses surged by 136.17% to ¥15,286,389.83[5] - Total operating revenue for Q1 2024 reached ¥104,057,251.91, a 27.6% increase from ¥81,516,580.85 in Q1 2023[18] - Net profit for Q1 2024 was ¥16,450,135.99, representing a 17.2% increase compared to ¥14,032,925.44 in Q1 2023[19] - Basic and diluted earnings per share for Q1 2024 were both ¥0.15, up from ¥0.13 in Q1 2023[20] Research and Development - The total R&D investment amounted to ¥9,830,599.42, which is an increase of 59.63% year-on-year, accounting for 9.45% of operating revenue[6] - Research and development expenses increased to ¥9,416,771.26 in Q1 2024, a 93.5% rise from ¥4,862,883.56 in Q1 2023[18] Cash Flow and Liquidity - The net cash flow from operating activities decreased by 30.03% to ¥12,056,553.34 due to increased purchases and tax payments compared to the previous year[6] - The net cash flow from operating activities was $12,056,553.34, a decrease from $17,230,314.83 in the previous year, reflecting a decline of approximately 30.4%[23] - Total cash outflow from operating activities amounted to $246,448,493.20, compared to $212,654,728.95 in the prior year, indicating an increase of about 15.9%[23] - The ending balance of cash and cash equivalents was $162,063,707.10, down from $340,592,596.07 year-over-year, reflecting a decrease of approximately 52.4%[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,354,784,315.93, up 2.97% from the end of the previous year[6] - The company's current assets totaled CNY 588,915,044.04, a decrease from CNY 609,304,574.93, indicating a decline of about 3.5%[15] - The total liabilities increased to CNY 458,212,502.80 from CNY 435,629,416.65, marking an increase of approximately 5.6%[16] - The company's short-term borrowings rose significantly to CNY 92,626,876.38 from CNY 37,032,984.72, reflecting an increase of about 150%[16] - The non-current assets increased to CNY 765,869,271.89 from CNY 706,420,414.63, indicating a growth of approximately 8.4%[15] Shareholder Information - The company had a total of 5,714 common shareholders at the end of the reporting period[10] - The largest shareholder, Sichuan Saino Investment Co., Ltd., holds 37.5% of the shares, totaling 42,000,000 shares[10] - The total equity attributable to shareholders reached ¥896,426,600.62 in Q1 2024, compared to ¥879,928,271.27 in Q1 2023[17] Other Financial Metrics - The weighted average return on equity increased by 0.17 percentage points to 1.85%[6] - The company reported a significant increase in sales expenses, which rose to ¥23,176,474.16 in Q1 2024 from ¥19,325,393.63 in Q1 2023[18] - Cash paid for taxes increased significantly to $9,971,216.40 from $2,624,216.80, marking an increase of approximately 280.5%[23] - Cash paid to employees rose to $29,108,182.45 from $28,290,261.11, reflecting a slight increase of about 2.9%[23] - The impact of exchange rate changes on cash and cash equivalents was $57,063.84, compared to -$801,072.13 in the previous year, indicating a positive shift[23] Company Developments - The company has not reported any new product developments or market expansion strategies during this quarter[12]